Sildenafil Tablet, Film Coated
Product Images NDC 68788-7879

14 FDA label images from Preferred Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68788-7879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Sildenafilfigure7 (Sildenafilfigure7)

Sildenafilfigure7 (Sildenafilfigure7)
A bar chart illustrating the percentage of patients reporting improvement across four treatment groups: Placebo (24%, n=463), Sildenafil Citrate Tablets 25 mg (63%, n=214), 50 mg (74%, n=391), and 100 mg (82%, n=380). The x-axis represents treatment groups and the y-axis shows percentage reporting improvement.*
FDA Label Image

Sildenafil Tablets 100mg (Sildenafiltab100mg30s)

Sildenafil Tablets 100mg (Sildenafiltab100mg30s)
Label for Sildenafil Tablets 100 mg, generic for Viagra, film-coated oral tablets by Preferred Pharmaceuticals, Inc. The label shows dosage strength, manufacturer Camber Pharmaceuticals, storage instructions, and warnings. It includes directions for use in English and Spanish with blanks for tablet count and hours between doses, plus a barcode and QR code.*
FDA Label Image

Sildenafilfigure1 (Sildenafilfigure1)

Sildenafilfigure1 (Sildenafilfigure1)
A line graph comparing systolic blood pressure changes (mmHg) over 24 hours post-dose between Sildenafil 100 mg and placebo. The x-axis shows time post dose in hours, and the y-axis shows systolic blood pressure changes. Sildenafil and placebo are represented by distinct lines with markers, illustrating their pressure changes over time.*
FDA Label Image

Sildenafilfigure2 (Sildenafilfigure2)

Sildenafilfigure2 (Sildenafilfigure2)
A line graph comparing the change in blood pressure (mmHg) over time (hours) for two treatments: Placebo and Cilnidipine 10 mg. The x-axis represents time postdose in hours, and the y-axis shows the change in blood pressure from baseline.*
FDA Label Image

Sildenafilfigure3 (Sildenafilfigure3)

Sildenafilfigure3 (Sildenafilfigure3)
A line graph depicting the percent change in a variable over time postdose, measured in hours. The graph compares two conditions: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg, shown with blue and gray lines respectively, plotting their trends from 0 to 8 hours after administration.*
FDA Label Image

Sildenafilfigure4 (Sildenafilfigure4)

Sildenafilfigure4 (Sildenafilfigure4)
A line graph depicting plasma concentration (ng/mL) over time (hours) after dosing for two groups: one treated with Doxazosin plus Sildenafil 100 mg, and the other with Doxazosin plus placebo. The graph compares drug concentration levels from 0 to 8 hours post-dose.*
FDA Label Image

Sildenafilfigure5 (Sildenafilfigure5)

Sildenafilfigure5 (Sildenafilfigure5)
A pharmacokinetic line graph depicting plasma concentration of a drug in ng/mL on the vertical axis versus time post dose in hours on the horizontal axis. The graph shows the plasma concentration peaking shortly after administration of a commercial tablet, followed by a gradual decline over 24 hours.*
FDA Label Image

Sildenafilfigure6a (Sildenafilfigure6a)

Sildenafilfigure6a (Sildenafilfigure6a)
A bar chart depicting the percentage of patients at endpoint across various baseline scores from 0 to 5. The chart includes multiple bars for each baseline score, representing different categories labeled 0 to 5 in the legend. The y-axis shows the percentage of patients, ranging from 0 to 80%.*
FDA Label Image

Sildenafilfigure6b (Sildenafilfigure6b)

Sildenafilfigure6b (Sildenafilfigure6b)
A bar chart displaying the percentage of patients at endpoint across different baseline scores. The x-axis represents baseline scores ranging from 0 to 5, and the y-axis shows the percentage of patients. Bars are grouped and shaded in varying patterns, labeled from 00 to 5, illustrating patient distribution at each baseline score.*
FDA Label Image

Sildenafilheterologo1 (Sildenafilheterologo1)

FDA Label Image

Sildenafilheterologo2 (Sildenafilheterologo2)

Sildenafilheterologo2 (Sildenafilheterologo2)
Sildenafil 100 mg film-coated tablets by Preferred Pharmaceuticals, Inc. The image shows a blister pack with four tablets arranged in two rows. The pack is white with black text and graphics, including the brand mark 'HETERO' printed vertically in black.*
FDA Label Image

Sildenafilstructure (Sildenafilstructure)

Sildenafilstructure (Sildenafilstructure)
Chemical structure diagram of sildenafil and its chemical salt form. The image depicts the molecular arrangement of sildenafil and its associated acid component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.